Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
TriPRIL CAR T Cells in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Status
- RECRUITING
- Phase
- PHASE3
A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
- Status
- RECRUITING
- Phase
- N/A
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide
- Status
- UNKNOWN
- Phase
- PHASE4
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2